These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 32860345)
21. Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome. Kessler SK; McCarthy A; Cnaan A; Dlugos DJ Epilepsy Res; 2015 May; 112():18-26. PubMed ID: 25847334 [TBL] [Abstract][Full Text] [Related]
22. Treatment of medically refractory seizures with responsive neurostimulation: 2 pediatric cases. Kokoszka MA; Panov F; La Vega-Talbott M; McGoldrick PE; Wolf SM; Ghatan S J Neurosurg Pediatr; 2018 Apr; 21(4):421-427. PubMed ID: 29393811 [TBL] [Abstract][Full Text] [Related]
23. Patient family engagement and partnership: Pilot survey results in assessing behavior, communication, and quality of life in children with Lennox-Gastaut syndrome and other drug-resistant epilepsy. Bliss ND; Patel AD; Dixon-Salazar T; Zhang L; LoPresti MA; Carroll M; Rosenman M; Lam S Epilepsy Behav; 2023 Nov; 148():109451. PubMed ID: 37783029 [TBL] [Abstract][Full Text] [Related]
24. Responsive Neurostimulation for People With Drug-Resistant Epilepsy and Autism Spectrum Disorder. Fields MC; Marsh C; Eka O; Johnson EA; Marcuse LV; Kwon CS; Young JJ; LaVega-Talbott M; Kurukumbi M; Von Allmen G; Zempel J; Friedman D; Jette N; Singh A; Yoo JY; Blank L; Panov F; Ghatan S J Clin Neurophysiol; 2024 Jan; 41(1):64-71. PubMed ID: 35512185 [TBL] [Abstract][Full Text] [Related]
25. The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome. Anvekar P; Lohana P; Elmahal M; Ali SR Cureus; 2021 Jul; 13(7):e16784. PubMed ID: 34513391 [TBL] [Abstract][Full Text] [Related]
26. Neuromodulation of the centromedian thalamic nuclei in the treatment of generalized seizures and the improvement of the quality of life in patients with Lennox-Gastaut syndrome. Velasco AL; Velasco F; Jiménez F; Velasco M; Castro G; Carrillo-Ruiz JD; Fanghänel G; Boleaga B Epilepsia; 2006 Jul; 47(7):1203-12. PubMed ID: 16886984 [TBL] [Abstract][Full Text] [Related]
27. Responsive neurostimulation for pediatric patients with drug-resistant epilepsy: a case series and review of the literature. Curtis K; Hect JL; Harford E; Welch WP; Abel TJ Neurosurg Focus; 2022 Oct; 53(4):E10. PubMed ID: 36183183 [TBL] [Abstract][Full Text] [Related]
28. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients. Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898 [TBL] [Abstract][Full Text] [Related]
30. Deep brain and cortical stimulation for epilepsy. Sprengers M; Vonck K; Carrette E; Marson AG; Boon P Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008497. PubMed ID: 28718878 [TBL] [Abstract][Full Text] [Related]
31. The refractory epilepsy screening tool for Lennox-Gastaut syndrome (REST-LGS). Piña-Garza JE; Boyce D; Tworek DM; Davis KA; Gatens H; Lai G; McGoldrick PE; Thomas B; Wolf SM Epilepsy Behav; 2019 Jan; 90():148-153. PubMed ID: 30537670 [TBL] [Abstract][Full Text] [Related]
32. Does response to vagus nerve stimulation for drug-resistant epilepsy differ in patients with and without Lennox-Gastaut syndrome? Dibué M; Greco T; Spoor JKH; Senft C; Kamp MA Brain Behav; 2023 Aug; 13(8):e3025. PubMed ID: 37386739 [TBL] [Abstract][Full Text] [Related]
33. Deep brain and cortical stimulation for epilepsy. Sprengers M; Vonck K; Carrette E; Marson AG; Boon P Cochrane Database Syst Rev; 2014 Jun; (6):CD008497. PubMed ID: 24937707 [TBL] [Abstract][Full Text] [Related]
34. Pontine and cerebral atrophy in Lennox-Gastaut syndrome. Newham BJ; Curwood EK; Jackson GD; Archer JS Epilepsy Res; 2016 Feb; 120():98-103. PubMed ID: 26808205 [TBL] [Abstract][Full Text] [Related]
35. The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials. Nabbout R; Thiele EA Epileptic Disord; 2020 Jan; 22(S1):23-28. PubMed ID: 31916540 [TBL] [Abstract][Full Text] [Related]
36. Myasthenia gravis in a pediatric patient with Lennox-Gastaut syndrome following responsive neurostimulation device implantation: illustrative case. Zuckerman DA; Beaudreault CP; Muh CR; McGoldrick PE; Wolf SM J Neurosurg Case Lessons; 2023 Nov; 6(22):. PubMed ID: 38011695 [TBL] [Abstract][Full Text] [Related]
37. Advances in the Treatment of Drug-Resistant Pediatric Epilepsy. Gonzalez-Giraldo E; Sullivan JE Semin Neurol; 2020 Apr; 40(2):257-262. PubMed ID: 32185791 [TBL] [Abstract][Full Text] [Related]
38. The efficacy and tolerability of auto-stimulation-VNS in children with Lennox-Gastaut syndrome. Abdelmoity SA; Abdelmoity AA; Riordan SM; Kaufman C; Le Pichon JB; Abdelmoity A Seizure; 2021 Mar; 86():168-174. PubMed ID: 33626436 [TBL] [Abstract][Full Text] [Related]
39. Electroencephalographic and magnetic resonance correlations in children with intractable seizures of Lennox-Gastaut syndrome and epilepsia partialis continua. Velasco AL; Boleaga B; Santos N; Velasco F; Velasco M Epilepsia; 1993; 34(2):262-70. PubMed ID: 8453934 [TBL] [Abstract][Full Text] [Related]